NYSE: WAT |
| Healthcare / Medical Diagnostics & Research / USA |
328.58 | +7.14 | +2.22% | Vol 518.62K | 1Y Perf -6.72% |
Jun 24th, 2022 16:04 DELAYED |
BID | 131.16 | ASK | 372.10 | ||
Open | 325.48 | Previous Close | 328.58 | ||
Pre-Market | - | After-Market | 328.58 | ||
- - | - -% |
Target Price | 354.80 | Analyst Rating | Hold 2.60 | |
Potential % | 7.98 | Finscreener Ranking | ★ 40.22 | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★★ 45.31 | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | ★★★+ 55.23 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | — - | |
Price Range Ratio 52W % | 28.78 | Earnings Rating | Sell | |
Market Cap | 19.79B | Earnings Date | 2nd Aug 2022 | |
Alpha | 0.00 | Standard Deviation | 0.08 | |
Beta | 0.85 |
Today's Price Range 324.10328.71 | 52W Range 288.32428.22 | 5 Year PE Ratio Range 17.70880.80 |
Summary:
Buy
Technical Indicators: | Neutral |
Moving Averages: | Strong Buy |
Performance | |||
---|---|---|---|
1 Week | 5.71% | ||
1 Month | 6.75% | ||
3 Months | 0.80% | ||
6 Months | -9.16% | ||
1 Year | -6.72% | ||
3 Years | 54.71% | ||
5 Years | 77.16% | ||
10 Years | 313.20% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 34.93 | |||
ROE last 12 Months | 237.61 | |||
ROA (5Y Avg) | 11.41 | |||
ROA last 12 Months | 23.20 | |||
ROC (5Y Avg) | 18.42 | |||
ROC last 12 Months | 37.39 | |||
Return on invested Capital Q | 8.64 | |||
Return on invested Capital Y | 11.30 | |||
Assets Turnover | 1.00 | |||
Receivables Turnover | 5.00 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
27.20 | ||||
49.94 | ||||
6.53 | ||||
26.30 | ||||
33.20 | ||||
11.80 | ||||
-62.98 | ||||
6.22 | ||||
19.75B | ||||
Forward PE | 23.49 | |||
PEG | 3.02 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.60 | ||||
2.30 | ||||
0.80 | ||||
4.08 | ||||
19.20 | ||||
Leverage Ratio | 9.40 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
58.60 | ||||
30.10 | ||||
34.80 | ||||
29.40 | ||||
24.56 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
2.87B | ||||
47.61 | ||||
4.97 | ||||
3.90 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q01 2022 | 2.32 | 2.80 | 20.69 |
Q04 2021 | 3.47 | 3.67 | 5.76 |
Q03 2021 | 2.34 | 2.66 | 13.68 |
Q02 2021 | 2.24 | 2.60 | 16.07 |
Q01 2021 | 1.57 | 2.29 | 45.86 |
Q04 2020 | 2.87 | 3.65 | 27.18 |
Q03 2020 | 1.91 | 2.16 | 13.09 |
Q02 2020 | 1.53 | 2.10 | 37.25 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
6/2022 QR | 2.63 | -5.40 | Negative |
9/2022 QR | 2.71 | -3.56 | Negative |
12/2022 FY | 12.05 | 1.69 | Positive |
12/2023 FY | 13.23 | 1.85 | Positive |
Next Report Date | 2nd Aug 2022 |
Estimated EPS Next Report | 2.63 |
Estimates Count | 7 |
EPS Growth Next 5 Years % | 9.00 |
Volume Overview | |
---|---|
Volume | 518.62K |
Shares Outstanding | 60.24K |
Shares Float | 53.27M |
Trades Count | 13.33K |
Dollar Volume | 169.81M |
Avg. Volume | 454.14K |
Avg. Weekly Volume | 515.38K |
Avg. Monthly Volume | 427.57K |
Avg. Quarterly Volume | 419.45K |
Waters Corporation (NYSE: WAT) stock closed at 328.58 per share at the end of the most recent trading day (a 2.22% change compared to the prior day closing price) with a volume of 518.62K shares and market capitalization of 19.79B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 7400 people. Waters Corporation CEO is Udit Batra.
The one-year performance of Waters Corporation stock is -6.72%, while year-to-date (YTD) performance is -11.81%. WAT stock has a five-year performance of 77.16%. Its 52-week range is between 288.32 and 428.22, which gives WAT stock a 52-week price range ratio of 28.78%
Waters Corporation currently has a PE ratio of 27.20, a price-to-book (PB) ratio of 49.94, a price-to-sale (PS) ratio of 6.53, a price to cashflow ratio of 26.30, a PEG ratio of 2.32, a ROA of 23.20%, a ROC of 37.39% and a ROE of 237.61%. The company’s profit margin is 24.56%, its EBITDA margin is 34.80%, and its revenue ttm is $2.87 Billion , which makes it $47.61 revenue per share.
Of the last four earnings reports from Waters Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.63 for the next earnings report. Waters Corporation’s next earnings report date is 02nd Aug 2022.
The consensus rating of Wall Street analysts for Waters Corporation is Hold (2.6), with a target price of $354.8, which is +7.98% compared to the current price. The earnings rating for Waters Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Waters Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Waters Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 11.87, ATR14 : 10.23, CCI20 : 11.15, Chaikin Money Flow : 0.13, MACD : -0.84, Money Flow Index : 31.28, ROC : -4.13, RSI : 53.88, STOCH (14,3) : 60.22, STOCH RSI : 1.00, UO : 52.43, Williams %R : -39.78), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Waters Corporation in the last 12-months were: Christopher A. Kuebler (Option Excercise at a value of $354 840), Christopher A. Kuebler (Sold 7 000 shares of value $2 531 980 ), Edward Conard (Option Excercise at a value of $303 760), Edward Conard (Sold 4 000 shares of value $1 344 040 ), Gary E. Hendrickson (Option Excercise at a value of $2 000 792), Gary E. Hendrickson (Sold 5 962 shares of value $2 001 600 ), Linda Baddour (Option Excercise at a value of $231 097), Linda Baddour (Sold 1 260 shares of value $515 327 ), Michael J. Berendt (Sold 4 806 shares of value $1 918 635 ), Thomas P. Salice (Sold 8 500 shares of value $3 357 500 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Hold | Hold | Hold |
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales, Waters generates 59% from pharmaceutical customers, 30% from industrial clients, and 11% from academic/government institutions.
CEO: Udit Batra
Telephone: +1 508 478-2000
Address: 34 Maple Street, Milford 01757, MA, US
Number of employees: 7 400
Sat, 21 May 2022 04:15 GMT Waters (WAT) Gets a Hold Rating from Robert W. Baird
- TipRanks. All rights reserved.Sat, 21 May 2022 04:06 GMT Waters (WAT) Receives a Hold from SVB Securities
- TipRanks. All rights reserved.Wed, 18 May 2022 09:03 GMT Waters (WAT) Receives a Hold from Jefferies
- TipRanks. All rights reserved.Thu, 05 May 2022 03:55 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: Waters (WAT) and Zimmer Biomet Holdings (ZBH)
- TipRanks. All rights reserved.Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE EDGX Top real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2022. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.